Vecuronium-associated axonal motor neuropathy: a variant of critical illness polyneuropathy?

@article{Geller2001VecuroniumassociatedAM,
  title={Vecuronium-associated axonal motor neuropathy: a variant of critical illness polyneuropathy?},
  author={Thomas J. Geller and Kitti Kaiboriboon and Glen A. Fenton and Ghazala R. Hayat},
  journal={Neuromuscular Disorders},
  year={2001},
  volume={11},
  pages={579-582}
}
Neuromuscular blocking agents are routinely used as an adjunct therapy for critically ill patients. Unlike many neuromuscular blocking agents, vecuronium does not cause significant histamine release, which may lead to bronchoconstriction. Due to a short duration of action and limited accumulation, vecuronium has been widely used. Prolonged ventilatory dependence due to persistent neuromuscular blockade has been reported in patients treated with vecuronium. We report a case of an 8-year-old girl… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 13 CITATIONS

Similar Papers

Loading similar papers…